# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3239920 | B | Inhibition of SARS coronavirus papain-like protease (amino acids 1541 to 1855) expressed in Escherichia coli BL21 (DE3) cells assessed as decrease in AMC release using Z-RLRGG-AMC as substrate by multimode plate reader analysis | SARS coronavirus | 31 | cell-based format | Scientific Literature | ||
2. | ALA3238619 | F | Antiviral activity against SARS coronavirus infected in african green monkey Vero E6 cells assessed as cell viability after 48 hrs by Cell Titer-Glo luminescent assay | Severe acute respiratory syndrome-related coronavirus | 9 | organism-based format | Scientific Literature | ||
3. | ALA3238620 | A | Cytotoxicity against african green monkey Vero E6 cells assessed as cell viability after 48 hrs by Cell Titer-Glo luminescent assay | Chlorocebus sabaeus | 6 | cell-based format | Scientific Literature | ||
4. | ALA3238621 | A | Therapeutic index, ratio of CC50 for african green monkey Vero E6 cells to EC50 for SARS coronavirus infected in african green monkey Vero E6 cells | 6 | cell-based format | Scientific Literature | |||
5. | ALA3238622 | A | Cytotoxicity against human HEK293 cells assessed as cell viability after 48 hrs by Cell Titer-Glo luminescent assay | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
6. | ALA3238625 | B | Inhibition of SARS coronavirus papain-like protease (amino acids 1541 to 1855) expressed in Escherichia coli BL21 (DE3) cells assessed as decrease in AMC release using Z-RLRGG-AMC as substrate by serum shift assay based multimode plate reader analysis in presence of 5 to 20% human serum albumin | SARS coronavirus | 6 | cell-based format | Scientific Literature |